Development of New Anticoagulants : Present and FutureHARENBERG, Job.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 8, pp 779-793, issn 0094-6176, 15 p.Article

GlycoaminoglycansHARENBERG, Job.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, issn 0094-6176, 126 p.Serial Issue

Basic and clinical considerations of heparins. Part IHARENBERG, Job.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 1, issn 0094-6176, 97 p.Conference Proceedings

Basic and clinical considerations of heparins. Part IIHARENBERG, Job.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 2, issn 0094-6176, 140 p.Serial Issue

Development of idraparinux and idrabiotaparinux for anticoagulant therapyHARENBERG, Job.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 811-815, issn 0340-6245, 5 p.Conference Paper

Effect of thrombin inhibitors and a glycoprotein IIb/IIIa receptor antagonist in an ex vivo human experimental thrombosis modelZOKAI, Kaweh; PIAZOLO, Lukas; HARENBERG, Job et al.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 531-536, issn 0094-6176Article

Monitoring of anticoagulant effects of direct thrombin inhibitorsFENYVESI, Tivadar; JÖRG, Ingrid; HARENBERG, Job et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 361-368, issn 0094-6176Article

Treatment of deep vein thrombosis : Is thrombosis regression a desirable endpoint?BREDDIN, H. K.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 2, pp 179-183, issn 0094-6176Article

Prolonged prophylaxis in postoperative medicineBERGQVIST, D.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 2, pp 149-154, issn 0094-6176Article

Prevention of recurrences after deep venous thrombosis : Role of low-molecular-weight heparinsPINI, M.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 1, pp 51-54, issn 0094-6176Conference Paper

Future of Anticoagulant TherapyHARENBERG, Job; WEHLING, Martin.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 5, pp 291-300, issn 1755-5914, 10 p.Article

New Anticoagulants in Atrial FibrillationHARENBERG, Job.Seminars in thrombosis and hemostasis. 2009, Vol 35, Num 6, pp 574-585, issn 0094-6176, 12 p.Article

Glycosaminoglycans: Anticoagulant and Nonanticoagulant ActionsHARENBERG, Job; CASU, Benito.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, issn 0094-6176, 82 p.Serial Issue

Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasmaALBAN, Susanne.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 503-511, issn 0094-6176Article

Development of direct thrombin inhibitors in comparison with glycosaminoglycansMARKWARDT, Fritz.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 523-530, issn 0094-6176Article

Current and Future Prospects for Anticoagulant Therapy : Inhibitors of Factor Xa and Factor IIaHARENBERG, Job; WEHLING, Martin.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 1, pp 39-57, issn 0094-6176, 19 p.Article

New anticoagulantsHARENBERG, Job; CASU, Benito.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, issn 0094-6176, 116 p.Conference Proceedings

Clinical monitoring of hirudin and direct thrombin inhibitorsNOWAK, Götz.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 537-541, issn 0094-6176Article

Heparin in patients with venous thromboembolism and contraindications to oral anticoagulant therapyMONREAL, M.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 1, pp 69-75, issn 0094-6176Conference Paper

The role of regioselectively sulfated and acetylated polysaccharide coatings of biomaterials for reducing platelet and plasma protein adhesionBAUMANN, Hanno.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 445-463, issn 0094-6176Article

Evidence that endogenous heparin activity deficiency may be an important factor in atherogenesisENGELBERG, H.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 2, pp 159-166, issn 0094-6176Article

Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis modelHARENBERG, Job; ZOKAI, Kawei; PIAZOLO, Lukas et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 379-382, issn 0094-6176Article

Determination of antithrombin-dependent factor xa inhibitors by prothrombin-induced clotting timeHARENBERG, Job; GIESE, Christina; HAGEDORN, Antje et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 503-507, issn 0094-6176, 5 p.Conference Paper

Effects of lepirudin, argatroban and melagatran and additional influence of phenprocoumon on ecarin clotting timeFENYVESI, Tivadar; JÖRG, Ingrid; WEISS, Christel et al.Thrombosis research. 2003, Vol 111, Num 1-2, pp 89-94, issn 0049-3848, 6 p.Article

Protein ZKEMKES-MATTHES, Bettina; MATTHES, Karl J.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 551-556, issn 0094-6176Article